MIT BRAIN TUMOUR DRUG CASE – ECJ DEFEAT
May 1st, 2006
STORIES BY KEITH NUTHALL
THE EUROPEAN Parliament's environment committee has moved to ease requirements for medicine manufacturers to always consider the potential affect on children of adult medicines that are proposed within a planned European Union (EU) directive. It has tabled amendments that would allow "justified derogations" from European Commission proposed requirements that firms present results of paediatric studies on medicines at the same time as those from human pharmaco-kinetic studies on adults. The committee also proposed amendments to ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.